• Harnessing AI to Revolutionize Drug Discovery

  • Jul 2 2024
  • Length: 28 mins
  • Podcast

Harnessing AI to Revolutionize Drug Discovery

Listen for free

View show details

  • Summary

  • In this episode, Tanuja Randery of AWS sits down with Dave Hallett, Chief Science Officer and Interim CEO of Exscientia, to discuss how the company is leveraging AI and cloud technology to transform the drug discovery process. Hallett explains Exscientia's approach to improving efficiency and patient success rates, and explores the importance of partnerships and building diverse, high-performing teams in the rapidly evolving landscape of scientific innovation.


    Resources:

    Amazon Bedrock: https://aws.amazon.com/bedrock/

    Amazon Q: https://aws.amazon.com/q/

    AWS Generative AI Innovation Center: https://aws.amazon.com/generative-ai/innovation-center/
    Show more Show less
activate_WEBCRO358_DT_T2
Economics
Show more Show less

What listeners say about Harnessing AI to Revolutionize Drug Discovery

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available